ATE235687T1 - Peptide mit spezifischer affinität für pacap typ 1 rezeptoren - Google Patents

Peptide mit spezifischer affinität für pacap typ 1 rezeptoren

Info

Publication number
ATE235687T1
ATE235687T1 AT97919648T AT97919648T ATE235687T1 AT E235687 T1 ATE235687 T1 AT E235687T1 AT 97919648 T AT97919648 T AT 97919648T AT 97919648 T AT97919648 T AT 97919648T AT E235687 T1 ATE235687 T1 AT E235687T1
Authority
AT
Austria
Prior art keywords
receptors
peptides
specific affinity
pacap
pacap type
Prior art date
Application number
AT97919648T
Other languages
English (en)
Inventor
Osamu Moro
Kawori Wakita
Manami Hyochi
Ethan A Lerner
Masahiro Tajima
Original Assignee
Shiseido Co Ltd
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd, Gen Hospital Corp filed Critical Shiseido Co Ltd
Application granted granted Critical
Publication of ATE235687T1 publication Critical patent/ATE235687T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT97919648T 1996-04-25 1997-04-23 Peptide mit spezifischer affinität für pacap typ 1 rezeptoren ATE235687T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/637,437 US6017533A (en) 1996-04-25 1996-04-25 Peptides having specific affinity to pituitary adenylate cyclase activating polypeptide type 1 receptors
PCT/JP1997/001394 WO1997040388A1 (en) 1996-04-25 1997-04-23 Peptides having specific affinity to pacap type 1 receptors

Publications (1)

Publication Number Publication Date
ATE235687T1 true ATE235687T1 (de) 2003-04-15

Family

ID=24555928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919648T ATE235687T1 (de) 1996-04-25 1997-04-23 Peptide mit spezifischer affinität für pacap typ 1 rezeptoren

Country Status (6)

Country Link
US (1) US6017533A (de)
EP (1) EP0900383B1 (de)
JP (1) JP2000513808A (de)
AT (1) ATE235687T1 (de)
DE (1) DE69720207T2 (de)
WO (1) WO1997040388A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182729A1 (en) * 2001-01-11 2002-12-05 Dicicco-Bloom Emanuel Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo
JP3993560B2 (ja) * 2001-08-30 2007-10-17 ステム セル セラピューティクス インコーポレイテッド 神経幹細胞の分化およびその治療用途
CA2460184A1 (en) * 2001-09-14 2003-03-27 Stem Cell Therapeutics Inc. Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
US20030054551A1 (en) * 2001-09-18 2003-03-20 Stem Cell Therapeutics Inc. Effect of growth hormone and IGF-1 on neural stem cells
CA2492442A1 (en) * 2002-07-31 2004-02-05 Stem Cell Therapeutics Inc. Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap)
US20050129687A1 (en) * 2003-11-03 2005-06-16 University Of Vermont And State Agricultural College Use of inhibitors of PACAP receptor activity for treatment of overactive bladder and pelvic floor pain syndrome
US7846898B2 (en) 2004-02-13 2010-12-07 Stem Cell Therapeutics Corp. Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
WO2007036033A1 (en) 2005-09-27 2007-04-05 Stem Cell Therapeutics Corp. Oligodendrocyte precursor cell proliferation regulated by prolactin
JP2009530234A (ja) * 2006-03-17 2009-08-27 ステム セル セラピューティクス コーポレイション 神経変性疾患の治療のためのｌｈまたはｈｃｇ、およびｅｐｏについての投与レジメン
WO2009033489A2 (en) * 2007-09-11 2009-03-19 Glostrup Hospital Selective pacl inhibitors for use in the treatment of migraine and headaches
EP3683237A1 (de) 2013-03-15 2020-07-22 Amgen Inc. Humane pac1-antikörper
JP6956631B2 (ja) 2014-09-15 2021-11-02 アムジェン インコーポレイテッド 二重特異性抗ｃｇｒｐ受容体／ｐａｃ１受容体抗原結合タンパク質及びその使用
EP3390447A1 (de) 2015-12-15 2018-10-24 Amgen Inc. Pacap-antikörper und verwendungen davon
MX2019008056A (es) 2017-01-05 2019-11-21 Univ California Agonistas del receptor pac1 (maxcaps) y usos de estos.
UY37753A (es) 2017-06-02 2018-11-30 Amgen Inc Antagonistas de péptido pac1
UY38050A (es) 2018-01-12 2019-07-31 Amgen Inc Anticuerpos pac1 y sus usos referencia cruzada a solicitudes relacionadas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5623050A (en) * 1991-08-22 1997-04-22 Takeda Chemical Industries, Ltd. Stable polypeptides having c-AMP production enhancing activity and the use thereof
EP0618291A3 (de) * 1993-02-26 1997-12-03 Takeda Chemical Industries, Ltd. PACAP-Rezeptor Protein, Verfahren zur dessen Herstellung und Verwendung davon
US5480864A (en) * 1993-08-06 1996-01-02 Shiseido Co., Ltd. Modified maxadilan protein, its preparation and use, and DNA encoding the protein
KR950007873A (ko) * 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
WO1996009318A1 (en) * 1994-09-22 1996-03-28 The Administrators Of The Tulane Educational Fund Method and pharmaceutical composition for prevention and treatment of brain damage

Also Published As

Publication number Publication date
DE69720207D1 (de) 2003-04-30
DE69720207T2 (de) 2003-09-25
EP0900383B1 (de) 2003-03-26
WO1997040388A1 (en) 1997-10-30
US6017533A (en) 2000-01-25
JP2000513808A (ja) 2000-10-17
EP0900383A1 (de) 1999-03-10

Similar Documents

Publication Publication Date Title
DE69720207D1 (de) Peptide mit spezifischer affinität für pacap typ 1 rezeptoren
NO20010284D0 (no) Peptidanaloger av hypofyse adenylat cyclase-aktiverende polypeptid (PACAP)
KR960701653A (ko) 펩타이드 yy의 유사체 및 그의 용도
WO2003070747A3 (en) Insulin and igf-1 receptor agonists and antagonists
TR199902997T2 (xx) "LH-RH peptit analoglar�, bunlar�n kullan�mlar� ve bunlar� i�eren farmas�tik terkipler"
NZ503850A (en) April - a novel protein with growth effects
TW343198B (en) Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
TR199901968T2 (xx) Sabit s�v� interferon form�lleri.
SI1642972T1 (sl) Terapevtske uporabe BR X topnih receptorjev
DE69838143D1 (de) Antimikrobielle peptide
WO2001072771A3 (en) Insulin and igf-1 receptor agonists and antagonists
NZ333606A (en) Isolated peptides derived from MAGE-2
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
ATE542138T1 (de) Her-2-bindungsantagonisten
Orloff et al. Characterization of canine renal receptors for the parathyroid hormone-like protein associated with humoral hypercalcemia of malignancy
ATE362939T1 (de) Dimere von thrombinpeptidderivaten
DE69528531D1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
ES2017028A6 (es) Procedimiento para preparar antagonistas de bombesina.
DE3751398D1 (de) Substrat-Peptide.
HUP0003396A1 (hu) Szomatosztatin antagonista peptidek
AU2865801A (en) Therapeutic peptides
ES2122921A1 (es) Proteinas recombinantes de fusion del virus del sindrome reproductivo y respiratorio porcino (prsv) y su empleo en diagnostico.
Kimura et al. Total synthesis of human parathyroid hormone (1–84)
PT745093E (pt) Oligopeptidos novos com afinidade para receptores opioides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties